{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T04:29:41Z","timestamp":1780892981880,"version":"3.54.1"},"reference-count":27,"publisher":"Baishideng Publishing Group Inc.","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJC"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4330\/wjc.v9.i6.553","type":"journal-article","created":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T09:14:57Z","timestamp":1498209297000},"page":"553","source":"Crossref","is-referenced-by-count":3,"title":["Interferon related pericarditis: Review"],"prefix":"10.4330","volume":"9","author":[{"given":"Kazuaki","family":"Nishio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Arase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","unstructured":"Mansat-Krzyzanowska E, Dr\u00e9no B, Chiffoleau A, Litoux P. [Cardiovascular manifestations associated with interferon alfa-2A]. Ann Med Interne (Paris) 1991;142:576-581."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.37.905"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Georg M, Walker B. Hepatitis C virus infection. N Engl J Med 2001;345:41-52 [DOI 10.1056\/NEJM200107053450107].","DOI":"10.1056\/NEJM200107053450107"},{"key":"ref4","unstructured":"Fava S, Luoni M, Stioui S. Pericarditis during interferon-alpha therapy in chronic myelogenous leukemia. Haematologica 1996;81:484."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s100670050081"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0399-8320(04)94929-9"},{"key":"ref7","unstructured":"Gressens B, Gohy P. Pericarditis due to interferon-alpha therapy during treatment for chronic hepatitis C. Acta Gastroenterol Belg 2004;67:301-302."},{"key":"ref8","unstructured":"Benjamini O, Kimhi O, Lishner M. Severe pleuropericarditis and cardiomyopathy induced by high dose interferon alpha-2b. Isr Med Assoc J 2007;9:486-7."},{"key":"ref9","unstructured":"Hamdani I, Kochlef A, Belhadj N, Kharrat J, Ghorbel A. [Acute pericardite which has occurred during the treatment of chronic hepatitis C by the interferon alpha2A]. Tunis Med 2008;86:404-405."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v2.i9.358"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-11-30"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1342028"},{"key":"ref13","unstructured":"Interferon in CML. Br J Hospital Med 1988;1:77."},{"key":"ref14","unstructured":"Montastruc M, Reiffers J, Bilhou-Nabera C. Recombinant interferon alpha (IFN) as initial treatment for chronic myelogenous leukemia (CML). Journal Chronic Myeloid Leukemia, 2nd International Conference, Bologna. 1992;103."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(96)80113-9"},{"key":"ref16","unstructured":"Silva MO. Risk of autoimmune complications associated with interferon therapy. Gastroenterol Hepatol (N Y) 2012;8:540-542."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/5.4.224"},{"key":"ref18","unstructured":"Itoh Y, Okanoue T, Enjyo F, Morimoto M, Takeuchi T, Kagawa K, Kashima K. Elevated interleukin-6 and gamma-globulin during interferon therapy of hepatitis B. Am J Gastroenterol 1992;87:1485-1487."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111905"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-012-9334-y"},{"key":"ref21","unstructured":"Ors\u00e1gov\u00e1 I, Ro\u017dnovsk\u00fd L, Petrou\u0161ov\u00e1 L, Kone\u010dn\u00e1 M, Kabieszov\u00e1 L, Martinek J, Kloudov\u00e1 A, Pavliska L. [Investigation of autoimmunity markers during interferon alpha therapy of chronic hepatitis B and C - twenty years of experience]. Klin Mikrobiol Infekc Lek 2016;22:61-67."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2012.04.014"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1378\/chest.99.3.557"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-166-41043"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840190407"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-122-3-199502010-00002"}],"container-title":["World Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1949-8462\/full\/v9\/i6\/553.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T18:18:25Z","timestamp":1569521905000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1949-8462\/full\/v9\/i6\/553.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.4330\/wjc.v9.i6.553","relation":{},"ISSN":["1949-8462"],"issn-type":[{"value":"1949-8462","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}